• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-羟色胺及几种类似物对人体血小板的相对活性及摄取情况

Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.

作者信息

Born G V, Juengjaroen K, Michal F

出版信息

Br J Pharmacol. 1972 Jan;44(1):117-39. doi: 10.1111/j.1476-5381.1972.tb07244.x.

DOI:10.1111/j.1476-5381.1972.tb07244.x
PMID:5015032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1665693/
Abstract
  1. The specificity of platelet receptor sites for 5-HT uptake and for the rapid morphological change and aggregation was investigated with 5-hydroxy-tryptamine (5-HT) and seventeen analogues as well as with some antagonists of 5-HT.2. The analogues, with the exception of 5-hydroxy-N'N'-dibutyltryptamine, caused the rapid morphological change in platelets. In concentrations below those needed to produce the agonistic action (viz. 0.05-2.0 muM), these analogues themselves inhibited competitively the shape change caused by 5-HT.3. The velocity of change in shape caused by 5-HT was reduced in low Na media.4. Ten analogues produced platelet aggregation; three of these, viz. 5-methoxy-alpha-methyltryptamine, 5-hydroxy-alpha-methyltryptamine and 5-hydroxy-N'N'-diisopropyltryptamine), were approximately equipotent with 5-HT. Six analogues did not induce platelet aggregation.5. All the analogues which prevented the initial change in shape of platelets caused by 5-HT also inhibited its aggregating effect, apparently competitively with low K(i) values (0.02-1.6 muM).6. As with the inhibition of shape change, the inhibition of aggregation shows relatively low structural specificity of the receptor site.7. Methysergide was a potent inhibitor of shape change and aggregation (K(i) approximately 0.03 muM); imipramine was much less inhibitory (K(i) approximately 5-10 muM).8. Only one analogue (5-hydroxy-alpha-methyltryptamine) was taken up like 5-HT by platelets. All the other analogues inhibited the uptake of 5-HT by platelets (K(i)=0.2-2.7 muM).9. Methysergide was a weak inhibitor of 5-HT uptake (K(i) approximately 125 muM) whereas imipramine was very effective (K(i) approximately 0.3 muM).10. Our results show that the initial change in shape of platelets is required for and precedes aggregation. The structural specificity of the platelet receptor concerned with shape change and aggregation caused by 5-HT appears low whereas the uptake mechanism is a highly specific one. The uptake probably proceeds through more than one step, the relationship between the steps is not yet clear.
摘要
  1. 用5-羟色胺(5-HT)及其17种类似物以及一些5-HT拮抗剂研究了血小板受体部位对5-HT摄取、快速形态变化和聚集的特异性。

  2. 除5-羟基-N'N'-二丁基色胺外,这些类似物均能引起血小板的快速形态变化。在低于产生激动作用所需的浓度(即0.05 - 2.0μM)下,这些类似物自身竞争性抑制5-HT引起的形状变化。

  3. 在低钠培养基中,5-HT引起的形状变化速度降低。

  4. 10种类似物可引起血小板聚集;其中3种,即5-甲氧基-α-甲基色胺、5-羟基-α-甲基色胺和5-羟基-N'N'-二异丙基色胺,与5-HT的效力大致相当。6种类似物不诱导血小板聚集。

  5. 所有阻止5-HT引起的血小板初始形状变化的类似物也抑制其聚集作用,显然是通过低K(i)值(0.02 - 1.6μM)竞争性抑制。

  6. 与形状变化的抑制一样,聚集的抑制显示受体部位的结构特异性相对较低。

  7. 美西麦角是形状变化和聚集的有效抑制剂(K(i)约为0.03μM);丙咪嗪的抑制作用则小得多(K(i)约为5 - 10μM)。

  8. 只有一种类似物(5-羟基-α-甲基色胺)像5-HT一样被血小板摄取。所有其他类似物均抑制血小板对5-HT的摄取(K(i)=0.2 - 2.7μM)。

  9. 美西麦角是5-HT摄取的弱抑制剂(K(i)约为125μM),而丙咪嗪非常有效(K(i)约为0.3μM)。

  10. 我们的结果表明,血小板的初始形状变化是聚集所必需的且先于聚集。与5-HT引起的形状变化和聚集相关的血小板受体的结构特异性似乎较低,而摄取机制是高度特异性的。摄取可能通过多个步骤进行,各步骤之间的关系尚不清楚。

相似文献

1
Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.5-羟色胺及几种类似物对人体血小板的相对活性及摄取情况
Br J Pharmacol. 1972 Jan;44(1):117-39. doi: 10.1111/j.1476-5381.1972.tb07244.x.
2
Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.血小板的形态变化与聚集:腺苷、二磷酸、5-羟色胺及肾上腺素作用之间的相互影响
Br J Pharmacol. 1976 Feb;56(2):209-18. doi: 10.1111/j.1476-5381.1976.tb07444.x.
3
5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.5-羟色胺摄取与释放与兔血小板聚集的关系
J Physiol. 1969 Apr;201(2):409-23. doi: 10.1113/jphysiol.1969.sp008763.
4
5-Hydroxytryptamine and dopamine transport by rat and human blood platelets.大鼠和人血小板对5-羟色胺和多巴胺的转运
Br J Pharmacol. 1978 Feb;62(2):219-26. doi: 10.1111/j.1476-5381.1978.tb08449.x.
5
Effects of imipramine and some tryptamine derivatives on the efflux of 3H-5-hydroxytryptamine from rabbit platelets.丙咪嗪和一些色胺衍生物对兔血小板中3H-5-羟色胺流出的影响。
J Neural Transm Suppl. 1991;34:77-83. doi: 10.1007/978-3-7091-9175-0_10.
6
Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers.兔血小板中[3H] - 色胺的饱和摄取受到5 - 羟色胺摄取阻滞剂的抑制。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Nov;328(1):33-7. doi: 10.1007/BF00496102.
7
Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.来自对照受试者和氯丙嗪治疗受试者的人血小板中的血清素受体位点。
Prog Biochem Pharmacol. 1980;16:119-32.
8
Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.5-羟色胺受体阻断剂对5-羟色胺增强的人血小板聚集的抑制作用。
Biomed Biochim Acta. 1984;43(2):215-20.
9
Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter.多种色胺及相关化合物作为血小板5-羟色胺转运体底物的证据。
Naunyn Schmiedebergs Arch Pharmacol. 1992 Feb;345(2):129-36. doi: 10.1007/BF00165727.
10
Increase of human platelet serotonin uptake by atypical histamine receptors.非典型组胺受体对人血小板血清素摄取的增加作用。
Am J Physiol. 1994 Feb;266(2 Pt 2):R526-36. doi: 10.1152/ajpregu.1994.266.2.R526.

引用本文的文献

1
Editor's page: fundamentals in neurocardiology: the brain-platelet-coronary artery interface.编辑页:神经心脏病学基础:脑-血小板-冠状动脉界面
J Thromb Thrombolysis. 2008 Aug;26(1):74-7. doi: 10.1007/s11239-008-0255-5. Epub 2008 Jul 20.
2
Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.色胺:一种与多种神经精神疾病有关的色氨酸代谢物。
Metab Brain Dis. 1993 Mar;8(1):1-44. doi: 10.1007/BF01000528.
3
Naftopidil inhibits 5-hydroxytryptamine-induced platelet aggregation and 5-hydroxytryptamine uptake in platelets of healthy volunteers.
Eur J Clin Pharmacol. 1994;46(3):271-4. doi: 10.1007/BF00192561.
4
Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.酮色林(R 41,468),一种选择性5-HT2受体拮抗剂,对5-羟色胺诱导和增强的人血小板聚集的抑制作用。1982年。
Agents Actions. 1994 Dec;43(3-4):225-34. doi: 10.1007/BF01986694.
5
Increases in aggregation by and uptake of 5-hydroxytryptamine with platelets from rabbits treated with chlorpromazine.氯丙嗪处理的兔血小板对5-羟色胺的聚集作用及摄取增加。
Br J Pharmacol. 1980 May;69(1):113-8. doi: 10.1111/j.1476-5381.1980.tb10889.x.
6
Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers.兔血小板中[3H] - 色胺的饱和摄取受到5 - 羟色胺摄取阻滞剂的抑制。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Nov;328(1):33-7. doi: 10.1007/BF00496102.
7
Tryptamine transport in rat brain slices: a comparison with 5-hydroxytryptamine.大鼠脑片中色胺转运:与5-羟色胺的比较。
Neurochem Res. 1984 May;9(5):617-28. doi: 10.1007/BF00964508.
8
Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.腺苷5-二磷酸拮抗剂与人类血小板:无证据表明聚集和刺激型腺苷酸环化酶的抑制作用由不同受体介导。
Br J Pharmacol. 1982 May;76(1):221-7. doi: 10.1111/j.1476-5381.1982.tb09210.x.
9
Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.酮色林(R 41 468),一种选择性5-HT2受体拮抗剂,对5-羟色胺诱导和增强的人血小板聚集的抑制作用。
Agents Actions. 1982 Jul;12(3):388-97. doi: 10.1007/BF01965409.
10
Proceedings: Potentiation and antagonism of neuronal responses to monoamines by methysergide and sotalol.论文集:甲基麦角新碱和索他洛尔对神经元对单胺类物质反应的增强及拮抗作用
Br J Pharmacol. 1974 Mar;50(3):445P.

本文引用的文献

1
Source of 'serotonin' in serum.血清中“血清素”的来源。
Nature. 1951 Sep 1;168(4270):385. doi: 10.1038/168385b0.
2
The mechanism of serotonin and catecholamine uptake by platelets.血小板摄取血清素和儿茶酚胺的机制。
J Pharmacol Exp Ther. 1959 Oct;127:96-102.
3
The estimation of 5-hydroxytryptamine (serotonin) in biological tissues.生物组织中5-羟色胺(血清素)的测定。
J Biol Chem. 1955 Jul;215(1):337-44.
4
Spectrophotofluorometric assay in the visible and ultraviolet.可见和紫外分光光度荧光测定法
Science. 1955 Jul 1;122(3157):32-3. doi: 10.1126/science.122.3157.32.
5
THE INITIAL CHANGES IN PLATELET MORPHOLOGY FOLLOWING THE ADDITION OF ADENOSINE DIPHOSPHATE.添加二磷酸腺苷后血小板形态的初始变化。
J Atheroscler Res. 1965 Jul-Aug;5(4):440-4. doi: 10.1016/s0368-1319(65)80081-3.
6
PLATELET CLUMPING IN VITRO.体外血小板聚集
Br J Haematol. 1964 Jan;10:78-93. doi: 10.1111/j.1365-2141.1964.tb00681.x.
7
An easy method to determine the serotonin content of human platelets.一种测定人体血小板中血清素含量的简便方法。
J Clin Pathol. 1962 Mar;15(2):191-3. doi: 10.1136/jcp.15.2.191.
8
The fate of 5-hydroxytryptamine in a smooth muscle and in connective tissue.5-羟色胺在平滑肌和结缔组织中的命运。
J Physiol. 1962 Apr;161(1):160-74. doi: 10.1113/jphysiol.1962.sp006879.
9
Aggregation of blood platelets by adenosine diphosphate and its reversal.二磷酸腺苷引起的血小板聚集及其逆转
Nature. 1962 Jun 9;194:927-9. doi: 10.1038/194927b0.
10
The uptake of 5-hydroxytryptamine by blood platelets in the cold.低温下血小板对5-羟色胺的摄取。
J Physiol. 1959 Jun 23;147(1):153-61. doi: 10.1113/jphysiol.1959.sp006230.